Gene: LDAF1
Official Full Name: lipid droplet assembly factor 1provided by HGNC
Gene Summary: Involved in lipid droplet formation. Located in endoplasmic reticulum membrane and lipid droplet. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16583 | LDAF1 Knockout cell line (HeLa) | Human | LDAF1 | 1:3~1:6 | Negative | Online Inquiry |
KO16584 | LDAF1 Knockout cell line (HCT 116) | Human | LDAF1 | 1:2~1:4 | Negative | Online Inquiry |
KO16585 | LDAF1 Knockout cell line (HEK293) | Human | LDAF1 | 1:3~1:6 | Negative | Online Inquiry |
KO16586 | LDAF1 Knockout cell line (A549) | Human | LDAF1 | 1:3~1:4 | Negative | Online Inquiry |
LDAF1 Gene Knockout Cell Lines are genetically engineered cellular models in which the LDAF1 gene has been precisely inactivated. These cell lines are instrumental for researchers studying the functional implications of the LDAF1 gene, which is known to play a crucial role in various biological processes, including cell signaling, proliferation, and apoptosis. Utilizing CRISPR/Cas9 technology or other gene-editing methods, the LDAF1 Gene Knockout Cell Lines have been designed to facilitate the exploration of gene function, allowing scientists to elucidate the molecular mechanisms underpinning various diseases.
The primary function of these knockout cell lines lies in their ability to mimic pathological states by eliminating the expression of the LDAF1 protein. This functional disruption can provide insights into associated pathways that may contribute to disease progression, particularly in contexts like cancer biology or metabolic disorder studies. Furthermore, the LDAF1 Gene Knockout Cell Lines serve as invaluable tools for drug discovery and testing, enabling researchers to assess the efficacy and specificity of therapeutic agents targeting related pathways.
In terms of scientific importance, these cell lines bolster research by offering a more accurate in vitro model for human disease. They enable the investigation of genetic interactions and cellular responses in a controlled setting that would be challenging to conduct in vivo. Compared to traditional models, such as whole organisms or non-specific cell lines, LDAF1 Gene Knockout Cell Lines provide a higher degree of specificity and predictability, which enhances reproducibility and reliability of experimental data.
A key advantage of our LDAF1 Gene Knockout Cell Lines lies in their characterization and validation by extensive genomic and phenotypic analyses, ensuring that researchers receive a product of the highest quality. Furthermore, their compatibility with a wide range of experimental manipulations, such as gene reintroduction or combinatorial gene editing approaches, makes them a versatile addition to any laboratory focused on molecular biology or translational research.
Investing in LDAF1 Gene Knockout Cell Lines is crucial for researchers and clinicians aiming to advance their understanding of gene function and associated therapeutic avenues. Our company's expertise in developing cutting-edge genetic tools ensures that these cell lines meet stringent standards, thus supporting your research objectives with reliable and innovative solutions. With our commitment to quality and scientific integrity, we continue to empower the research community with products that are designed for success.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.